210. 単心室症
[臨床試験数:47,薬物数:54(DrugBank:23),標的遺伝子数:32,標的パスウェイ数:66

Searched query = "Single Ventricle", "SV", "Single ventricle heart defect", "Univentricular heart", "UVH", "Single ventricular circulation syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03088345
(ClinicalTrials.gov)
March 6, 201728/2/2017Early Use of Vasopressin in Post-Fontan ManagementUse of Arginine Vasopressin in Early Postoperative Management After Fontan PalliationCirculatory Perfusion Disorder;Congenital Heart Disease;Single-ventricleDrug: Vasopressin, Arginine;Drug: PlaceboMedical College of WisconsinNULLCompletedN/A18 YearsAll20Phase 2;Phase 3United States
2NCT02975999
(ClinicalTrials.gov)
December 201622/9/2016Use of Vasopressin Following the Fontan OperationUse of Vasopressin Following the Fontan Operation: Both Pilot and Multicenter StudiesPleural Effusion;Single-ventricleDrug: Vasopressin;Drug: Normal SalineAdvocate Health CareNULLSuspended18 Months7 YearsAll84Phase 2;Phase 3United States